Treatment of moderately increased homocyteine levels is premature;Behandeling van matig verhoogde homocysteïnespiegels is prematuur

Huisarts en Wetenschap

Volumn 45, Issue 8, 2002, Pages 409-410

  Wiersma, Tj ^a   Assendelft, W J J ^a  

^a DUTCH COLLEGE OF GENERAL PRACTITIONERS   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN; HOMOCYSTEINE;

ATHEROSCLEROSIS; BLOOD LEVEL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE SEVERITY; HORMONE SUBSTITUTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERHOMOCYSTEINEMIA; HYPERTENSION; RISK FACTOR; SHORT SURVEY; VITAMIN SUPPLEMENTATION;

EID: 0036070801     PISSN: 00187070     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (10)

1. Hyperhomocysteïnemie: Opsporen en behandelen?
2. Vascular complications of severe hyperhomocysteinemia in patients with homocystinuria due to cystathionine b-synthase deficiency: Effects of homocysteine-lowering therapy
3. Vitamin supplements and cardiovascular risk: Review of the randomized trials of homocysteine-lowering vitamin supplements
4. Homocysteine and cardiovascular disease: Cause or effect?
5. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
6. Hormone replacement therapy and heart disease prevention. Experimentation trumps observation
7. Natriumgebruik tijdens de zwangerschap
8. Standaarden: Ontwikkeling en actualisering
9. Homocyst(e)ine and cardiovascular disease: A critical review of the epidemiologic evidence